KINTOR PHARMA-B (09939) received an increase of 1.2625 million shares by Chairman Tong Youzhi.

KINTOR PHARMA-B (09939) announced that the Board of Directors has been notified by Dr. Tong Youzhi (Dr. Tong, Chairman of the Board of Directors, Executive Director and Chief Executive Officer) that he has increased his holdings of the company's shares by purchasing approximately 3.32 million Hong Kong dollars (with an average transaction price of HK$2.63 per share, with a purchase price range of HK$2.23 to HK$2.89 per share) through its wholly-owned company KT International Investment Limited on the open market from April 2, 2026 to May 28, 2026 (inclusive of both days). In addition, Dr. Tong exercised the rights granted by 1.25 million restricted stock units awarded under the company's 2020 employee incentive plan at a cost of approximately HK$1.09 million. These shares were allocated on March 31, 2026. Dr. Tong now holds a total of 2.5125 million shares of the company, representing approximately 0.5039% of the total issued share capital of the company as of the date of this announcement. According to publicly available information and the knowledge of the Board of Directors, the company still maintains a sufficient public holding of shares after this increase in holdings. Dr. Tong stated that he is confident in the overall development prospects and commercial transformation of the group. Subject to applicable laws and regulations, Dr. Tong does not rule out the possibility of further increasing his holdings in the company in the future. The Board of Directors believes that this increase in holdings demonstrates Dr. Tong's strong confidence in the company's topical innovative drugs, especially in the clinical progress and commercialization prospects of the hair loss prevention pipeline, as well as the growth potential and long-term investment value of the company.